These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 4814156)

  • 1. Failure of Shier's chemical vaccine to protect BALB-c mice against transplant and chemically induced tumors.
    Cook MM; Wagner AF; Larson VM; Tytell AA; Shen TY; Hilleman MR
    Proc Soc Exp Biol Med; 1974 Feb; 145(2):636-40. PubMed ID: 4814156
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of chemical carcinogenesis by viral vaccines.
    Whitmire CE; Huebner RJ
    Science; 1972 Jul; 177(4043):60-1. PubMed ID: 4339425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of immunosurveillance against chemically induced in situ tumors in mice.
    Andrews EJ
    J Natl Cancer Inst; 1974 Mar; 52(3):729-32. PubMed ID: 4826561
    [No Abstract]   [Full Text] [Related]  

  • 4. SV40 protection in myeloma oncogenesis.
    Reinisch CL
    Nature; 1973 Apr; 242(5398):470-1. PubMed ID: 4349562
    [No Abstract]   [Full Text] [Related]  

  • 5. The induction of tumour immunity in mice using glutaraldehyde-treated tumor cells.
    Sanderson CJ; Frost P
    Nature; 1974 Apr; 248(5450):690-1. PubMed ID: 4208483
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative analysis of the malignancy of tumors in mice induced by 20-methylcholanthrene].
    Viksler VKh; Iaroslavtseva OA; Lavroskiĭ VA
    Eksp Onkol; 1985; 7(5):21-4. PubMed ID: 4065015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of orally administered L-arginine HCl on the development of myeloma tumors in BABL/C mice following the injection of single cell suspensions, cell aggregates or tumor fragments; and on the growth of two ascites tumour cell lines.
    Pryme IF
    Cancer Lett; 1978 Jul; 5(1):19-23. PubMed ID: 688179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of chemically induced pulmonary tumors by treatment of strain A mice with murine sarcoma virus.
    Stoner GD; Kniazeff AJ; Shimkin MB; Hoppenstand RD
    J Natl Cancer Inst; 1974 Aug; 53(2):493-8. PubMed ID: 4367245
    [No Abstract]   [Full Text] [Related]  

  • 9. Preparation of a "chemical vaccine" against tumor progression.
    Shier WT
    Proc Natl Acad Sci U S A; 1971 Sep; 68(9):2078-82. PubMed ID: 4109066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to growth of 3-methylcholanthrene(3-MC)-induced primary tumours in BALB/c mice following pregnancy or immunization against foetal tissues.
    Chandradasa KD
    Eur J Cancer (1965); 1980 Sep; 16(9):1237-41. PubMed ID: 7227448
    [No Abstract]   [Full Text] [Related]  

  • 11. Tumor-specific immunogenicity of transplantable chemically induced tumors, as demonstrated by uptake of tritiated thymidine by lymphoid cells from isogenic and F1 hybrid mice.
    Phillips ME
    J Natl Cancer Inst; 1974 Dec; 53(6):1665-70. PubMed ID: 4436867
    [No Abstract]   [Full Text] [Related]  

  • 12. The morphological, biological, and antigenic characteristics of transplantable papillomas and keratinous cysts induced by methylcholanthrene.
    Andrews EJ
    Cancer Res; 1974 Nov; 34(11):2842-51. PubMed ID: 4422169
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of intratumor injection of live BCG on 3-methylcholanthrene-induced tumors of primary and early transplant generations in mice.
    Tanaka T
    Gan; 1974 Apr; 65(2):145-51. PubMed ID: 4600803
    [No Abstract]   [Full Text] [Related]  

  • 14. Transplantation immunity to individually unique antigens of chemically induced bladder tumors in mice.
    Wahl DV; Chapman WH; Hellström I; Hellström KE
    Int J Cancer; 1974 Jul; 14(1):114-21. PubMed ID: 4142461
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship of tumor immunogenicity to concentration of the oncogen.
    Prehn RT
    J Natl Cancer Inst; 1975 Jul; 55(1):189-90. PubMed ID: 1159812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical induction of subcutaneous tumors in BALB-c and Swiss mice infected with wild type C RNA viruses derived from BALB-c tissues.
    Salerno RA; Ramm GM; Whitmire CE
    Cancer Res; 1973 Jan; 33(1):69-77. PubMed ID: 4345153
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of cellular and humoral factors in the destruction of nascent plasma cell tumors.
    Yamada H; Yamada A; Hollander VP
    Cancer Res; 1969 Jul; 29(7):1420-7. PubMed ID: 5799160
    [No Abstract]   [Full Text] [Related]  

  • 18. Nongenetic variability in susceptibility to oncogenesis.
    Prehn RT
    Science; 1975 Dec; 190(4219):1095-6. PubMed ID: 1188386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphomas in BALB-c mice inoculated with supernatants from chemically induced sarcomas.
    Basombrio MA
    J Natl Cancer Inst; 1973 Oct; 51(4):1157-62. PubMed ID: 4355601
    [No Abstract]   [Full Text] [Related]  

  • 20. Biological behavior through successive transplant generations of transplantable tumors derived originally from primary chemically induced and spontaneous sources in mice.
    Wexler H; Orme SK; Ketcham AS
    J Natl Cancer Inst; 1968 Mar; 40(3):513-23. PubMed ID: 4296209
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.